エンザイグノスト B 単純ヘルペス／ IgG
Contents
1. 3 ul HIV HBV HCV2. PAN AA HSV 2 ce PAN
3. 2 8C 5 2 8C A gty p POD qG 2 8C 12 a 1 50 2 8C 4 5 1 2 8C 8 PA 2 8C 12
4. P N 6
5. 121C 1 2 Syndrome JAMA 1984 252 72 7 6 Erlich KS Hauer L Mills J Effects of long term acyclovir chemosuppression on serum IdG antibody to herpes simplex virus J Med Virol 1988 26 33 9 7 McClung H Seth P Rawls WE Relative concentrations in human sera of antibodies to cross reacting and specific antidens of herpes simplex virus types 1 and 2 Am J Epidemiol 1976 104 192 201 8 Lindenschmidt EG Erfahrungen mit dem Enzymimmunoassay In der Serodiagnostik bei Infektionen mit Viren der Herpesgruppe Immun Infekt 1981 9 140 6 9 Hadar T Sarov Specific I9G and IgA antibodies to herpes simplex virus HSV induced surface antiden in patients with HSV infections and in healthy adults J Med Virol 1984 14 201 7 10 Juto P Settergren B Specific serum IgA IgG and IgM antibody determination by a modified indirect ELISA technique in primary and recurrent herpes simpl
6. 1 2 8C 3 18 25C ho H ANAAMA lg6 VZV CMV p
7. BEP BEP 37 450nm 650nm 615 690nm 1 2 3 400uL 2 8C 200uL PN 1 A1 H P N 20uL P N 20uL
8. 1 25mL 0mL 1 ho 400mL 1 L o 1mL 10mL 1 E
9. MG 3 10 loG 3 2 130 1 230 1 2309 100 5 3 HSV 135 93 3 GR Ne IgG
10. 1 20 8 pe PA 2 8C 8 2 8C 2 8C 2 8C 5 0 15 25C 8 2 8C 1 19 2 8C 1 18 25C 1 2 8C 2 8C 3 ELISA I BEP BEP 1C 3 lt 4
11. HSV 1 s 12 896 HSV 2 HSV HSV 1 HSV 2 EU HCV In Vitro Diagnostic Direct HIV 1 E 1 ive in
12. IFA Fc 9 loG6 40 HSV 1 HSV 2 8196 HSV 1 8896 HSV 2
13. P 2 3 2 PIN 2 SV A2 HSV 20uL 1 15 8 5 37 1C 60 2 6 4
14. 7 8 37 9 0 100uL 1C 60 2 E 03mL BEP BEP TT P N 1 20 1 200uL P N 20HL
15. invali PAN dtestresut 2 BEP BEP P N P N AA
16. 96 X2 50mLX2 0 4mLX1 1mLX 1 12 5mLX4 3 1 1 1 1 3mLX4 30mL Xx 4 100mL X 3 100mLX2 24 1 12 5mL X 1 IgG POD loG amp E 2013 4 2 2008 10 1 0500AMYO0025000 G loG
17. IgM 56C 30 1 ks 18 25C 18 25C POD gG 1 50 250uL POD gG 1 12 5mL
18. 1 20 1 P N P N 20uL 100uL 18 25C 30 2 9 100uL 0 3 1 450nm 650nm 615 690nm BEP BEP 1 4
19. HSV 67 2 3 t 10096 116 98 396 HSV a CV HSV 96 n 4 s 7 0 MR
20. 6 C 06 o 08 AA 1 AA25 PAN 0 5 0 1 Logw X AAg 2 96 IG AA 25 _ A 1 2309 231 10
21. P N 18 18 POD gG 18 36 24 24 22 60 96 1 2 Corey L Spear PG Infections with herpes simplex Viruses 2 N Engl J Med 1986 314 749 57 Dummer JS Armstrond J Somers J et al Transmission of Infection with herpes simplex virus by renal transplantation JInfect Dis 1987 155 202 6 Cappel R Sprecher S Rickaert F de Cuyper F Immune response to a DNA free herpes simplex vaccine In man Arch Virol 1982 73 61 7 Greenberg MS Friedman H Cohen SG et al A comparative study of herpes simplex infections In renal transplant and leukemic patients J Infect Dis 1987 156 280 7 Quinnan GV Jr Masur H Rook AH et al Herpesvirus infections in the acquired Immune deficiency TEL 03 3493 8400 1 1 1 DL 114 019D 0WMXG 15C 0502
22. 9 CV CV IuM AmA Am HSV 115 99 HY 7 lt 2 oe 3 7 1 99 3 8910 HSV MoE HSV VZV 8 HSV HIV 15 AIDS HSV 96 6 A HSV 96 1 7 HV HBV HCV
23. AA AA HSV 1 HSV 2 HSV AA lt 0100 HSV I96 AA gt 0200 7 0 ADS Acyclovi HSV lgG 1
24. 20L P N 20HL BEP 60 2 37 1C 4 1 100pL AA 1 P N AA AA Reference AA 2096 BEP
25. he EU FDA HIV 2 HBV H UIG RUs POD 96 P N POD MG PAN 6
26. 1986 24 672 4 19 Wutzler P Doerr HW Farber et al Seroprevalence of herpes simplex virus type 1 and type 2 jn selected German populations relevance for the incidence of genital herpes J Med Virol 2000 61 201 7 20 Lafferty WE Downey L Celum C Wald A Herpes simplex virus type 1 as a cause of genital herpes impact on surveillance and prevention J Infect Dis 2000 181 1454 7 1 2 2 8C 1 12 2 12
27. OWMX SIEMENS IgG Enzygnost Anti HSV IgG 0 1 2 3 4 5 6 1 rn Anti HSV lgG Test plate Sample Buffer POD P N Anti HSV Reference P N POD gG Ant
28. ex Virus infection J Virol Methods 1988 20 45 55 11 Zweerink HJ Stanton LW Immune response to herpes simplex virus infections virus specific antibodies in sera from patients with recurrent facial infections Infect Immun 1981 31 624 30 12 Zweerink HJ Corey L Virus specific antibodies in sera from patients with genital herpes simplex virus infection Infect Immun 1982 37 413 21 13 Kuhn JE Klaffke K Munk K Braun RW HSV 1 gB and VZV gp ll crossreactive antibodies in human sera Arch Virol 1990 112 203 13 14 Mosca JD Bednarik DP Raj NB et al Activation of human immunodeficiency Virus by herpesvirus infection Identification of a region within the long terminal repeat that responds to a trans acting factor encoded by herpes simplex virus 1 Proc Natl Acad Sci USA 1987 84 7408 12 15 0strove JM Leonard J Weck KE et al Activation of the human immunodeficiency virus by herpes simplex virus type 1 J Virol 1987 61 3726 32 16 Halbert SP Kiefer DJ Friedman Kien AE Poiesz B Antibody levels for cytomegalovirus herpes simplex virus and rubella in patients with acquired immune deficiency syndrome J Clin Microbiol 1986 23 318 21 17 Baer GM Yager PA Studies of an outbreak of acute hepatitis A Il Antibody changes to cytomegalovirus and herpesvirus J Med Virol 1977 1 9 14 18 Gallo D Elimination of Fc receptor binding of human immunoglobulin G in immunofluorescence assays for herpes simplex virus antibodies J Clin Microbiol
29. i Human IgG POD Conjugate POD IgG Conjugate Buffer Mi crobiol Chromogen TMB lp uffer Substrate TMB Washing Solution POD Stopping Solution POD Color Solution blue for Enzygnost IgG 8 3 loG
Download Pdf Manuals
Related Search